Dr. May Pharma Consult GmbH

<body bgcolor="#FFFFFF" text="#000066" background="images/page_bg.gif" link="#0000CC" vlink="#0000CC" alink="#000066"> <p><font face="Arial, Helvetica, sans-serif" size="2"> <h2> Dr. May Pharma Consult is a specialised Healthcare Consulting Company<br> focussing on Mergers & Acquisitions, Licensing and Co-operation Agreements<br> as well as Strategy Consulting on a world-wide basis.<br> </h2> <br> <br> This is a frame based website.<br> Please use a webbrowser that supports frames!<br> <br><br><br> Below this line is just some content for web-indexing purposes <hr> <br><br> <img src="images/page_bg.gif" width="400" height="300" alt="otc mbo m&a jv j.v. drug pharma network merger medical medcine germany german zulassung workshop strategy marketing licensing key info generika generic fusion consult tax experts investment frankfurt divestment consulting pharmaconsult outlicensing negotiation manfred may lizenzierung inlicensing healthcare health care legal experts joint-venture arzneimittel akquisition acquisition pharmaindustrie marktforschung entry strategy entry concept due diligence secrecy agreement pharmaunternehmen pharmaconsulting unternehmensberater offering memorandum marketing strategy marketing concept unternehmungsberatung unternehmensberatung management consultant strategisches marketing pharmaceutical industry pharmaceutical company management consultancy information memorandum pharmaceutical industries pharmaceutical companies confidentiality agreement"><br> <a href="may-pharma-consult_0_home.html">may-pharma-consult_0_home.html</a><br> <a href="may-pharma-consult_1_companyprofile.html">may-pharma-consult_1_companyprofile.html</a><br> <a href="may-pharma-consult_2_services.html">may-pharma-consult_2_services.html</a><br> <a href="may-pharma-consult_3_references.html">may-pharma-consult_3_references.html</a><br> <a href="may-pharma-consult_3_references_l.html">may-pharma-consult_3_references_l.html</a><br> <a href="may-pharma-consult_3_references_r.html">may-pharma-consult_3_references_r.html</a><br> <a href="may-pharma-consult_3_references_t.html">may-pharma-consult_3_references_t.html</a><br> <a href="may-pharma-consult_4_contacts.html">may-pharma-consult_4_contacts.html</a><br> <a href="may-pharma-consult_4_contacts_maydetails.html">may-pharma-consult_4_contacts_maydetails.html</a><br> <a href="may-pharma-consult_4_directions.html">may-pharma-consult_4_directions.html</a><br> <a href="may-pharma-consult_4_directions_ea.html">may-pharma-consult_4_directions_ea.html</a><br> <a href="may-pharma-consult_4_directions_ffm.html">may-pharma-consult_4_directions_ffm.html</a><br> <a href="may-pharma-consult_4_directions_no.html">may-pharma-consult_4_directions_no.html</a><br> <a href="may-pharma-consult_4_directions_so.html">may-pharma-consult_4_directions_so.html</a><br> <a href="may-pharma-consult_4_directions_we.html">may-pharma-consult_4_directions_we.html</a><br> <a href="may-pharma-consult_4_impressum.html">may-pharma-consult_4_impressum.html</a><br> <a href="may-pharma-consult_5_pressreleases.html">may-pharma-consult_5_pressreleases.html</a><br> <a href="may-pharma-consult_5_pressreleases_01.html">may-pharma-consult_5_pressreleases_01.html</a><br> <a href="may-pharma-consult_5_pressreleases_02.html">may-pharma-consult_5_pressreleases_02.html</a><br> <a href="may-pharma-consult_5_pressreleases_03.html">may-pharma-consult_5_pressreleases_03.html</a><br> <a href="may-pharma-consult_5_pressreleases_04.html">may-pharma-consult_5_pressreleases_04.html</a><br> <a href="may-pharma-consult_5_pressreleases_05.html">may-pharma-consult_5_pressreleases_05.html</a><br> <a href="may-pharma-consult_5_pressreleases_06.html">may-pharma-consult_5_pressreleases_06.html</a><br> <a href="may-pharma-consult_5_pressreleases_07.html">may-pharma-consult_5_pressreleases_07.html</a><br> <a href="may-pharma-consult_5_pressreleases_08.html">may-pharma-consult_5_pressreleases_08.html</a><br> <a href="may-pharma-consult_5_pressreleases_09.html">may-pharma-consult_5_pressreleases_09.html</a><br> <a href="may-pharma-consult_5_pressreleases_10.html">may-pharma-consult_5_pressreleases_10.html</a><br> <br><br><br> Services More than 30 years experience in Top Management functions of the founder Dr. Manfred A. May in the Healthcare Industry and the existing international network are being utilised in the benefit of our customers. A highly qualified and committed team of collaborators in Europe, U.S.A., Latin America and Asia guarantees the efficient execution of assumed mandates/assignments. Examples of our services 1. Objective / wish of client Sell company/division plant/subsidiary product range product Activity MPC Definition of mandate Screening of potential buyers Key info for buyers (no-name-basis) Confidentiality Agreement Preparation Offering Memorandum Evaluate with client non binding offers Select companies for Due Diligence (DD) Assist client in preparation of DD and during DD as well as during negotiation phase Customer-benefits MPC concentrates on a few important assignments Management of clients can rely on - Specific background in Pharmaceutical Business/Operations - International network - Confidentiality Co-ordination of meetings, DD, including status-report Involvement of specialised legal and tax-experts during evaluation Phase and final negotiation Fast and effective process Mandate to buy a company, division, etc. is also a regular assignment of MPC. 2. Objective / wish of client Out-licensing of product (line or single product) Activity MPC Similar approach as under "sell" In addition: Analyse scientific background of product Comparison to competitive products Identify and present potential partner in Europe, Latin America, Asia Mandate to acquire a product or find other arrangements of Co-Marketing is also possible. Customer-benefits Client gets a fast feedback and overview on potential, value of product and parties definitely interested. 3. Objective / wish of client Strategy review Activity MPC Analysis of current objectives and performance with Top Management Prepare agenda to discuss change Suggest options of possible actions Organise and lead workshops Customer-benefits Second opinion of experienced Management Co-ordination of complex process 4. Objective / wish of client Establish representation/own base in Germany/Europe/Latin America Activity MPC Define with client entry strategy Float entity Recruit people Implement strategy Company Profile Founded 1996 Owner Dr. Manfred Alexander May, Managing Director, 32 years experience in Top Management positions in Pharmaceutical Industry Employees 3 plus project-related Freelancer/Experts in Market research Marketing Distribution Regulatory Third party production Corporate finance Taxes Legal Clients Leading pharmaceutical companies Offices Headquarter: Bolongarostrasse 82 65929 Frankfurt am Main / Germany Phone: +49 / (0) 69 / 31 40 53 - 47 Fax: +49 / (0) 69 / 31 40 53 - 25 Email: info@may-pharma.com Branch: Am Grenzweg 17 64665 Alsbach-Haehnlein / Germany Phone: +49 / (0) 62 57 / 90 39 60 Fax: +49 / (0) 62 57 / 68 75 9 Services Dr. May Pharma Consult (MPC) concentrates on: M&A Joint-Venture arrangements In- and out-licensing Marketing and strategy audits Entry strategies into European, Latin American and other markets Major Participation CGC Cramer-Gesundheits-Consulting GmbH www.cgc-pr.com The leading PR and Communication Company in the Healthcare sector in Germany. CGC operates with approx. 20 Scientists (natural sciences). Clients of CGC: Altana Aventis Nattermann ICN Pharmaceuticals Innovacare Lilly Medice Merck<br> <h2>otc mbo m&a jv j.v. drug pharma network merger medical medcine germany german zulassung workshop strategy marketing licensing key info generika generic fusion consult tax experts investment frankfurt divestment consulting pharmaconsult outlicensing negotiation manfred may lizenzierung inlicensing healthcare health care legal experts joint-venture arzneimittel akquisition acquisition pharmaindustrie marktforschung entry strategy entry concept due diligence secrecy agreement pharmaunternehmen pharmaconsulting unternehmensberater offering memorandum marketing strategy marketing concept unternehmungsberatung unternehmensberatung management consultant strategisches marketing pharmaceutical industry pharmaceutical company management consultancy information memorandum pharmaceutical industries pharmaceutical companies confidentiality agreement</h2> Press Releases / Newspaper Articles Roland ArzneimittelTask Divest Varilind-DivisionResult Sold to Omega PharmaPress report / newspaper article "Omega Pharma acquires 'Varilind' from Roland Arzneimittel GmbH." Press report on 14th December 2001 Jamyr Vasconcellos BrazilTask Divest Dansk FlamaResult Sold to Cobalt Pharmaceuticals in 2001Press report / newspaper article No press release available BiotestTask Divest AstrapinResult Sold to Pharma HamelnPress report / newspaper article "Biotest trennt sich vom Generika-Geschäft" Press report on 3rd November 2000 AlpharmaTask Divest Oral Health Care DivisionResult Sold to Colgate in 2000Press report / newspaper article No press release available Global Health Care Partners (GHCP) / Donaldson, Lufkin&Jenrette Merchant Banking Partners (DLJMBP II)Task Invest in Pharma / Marketing & SalesResult GHCP / DLJMBP II acquire ThiemannPress report / newspaper article "Global Health Care Partners and DLJ Merchant Banking Partners II, L.P. to acquire Thiemann Arzneimittel GmbH" Press report on 18th July 2000 Global Health Care Partners (GHCP) / Donaldson, Lufkin&Jenrette Merchant Banking Partners (DLJMBP II)Task Invest in Pharma / TollmanufacturingResult Owners Allphamed Pharbil sold Group to GHCP / DLJMBP IIPress report / newspaper article "Zweitgrößter deutscher pharmazeutischer Auftragshersteller schließt sich mit amerikanischer Investmentgruppe zusammen" Press report on 17th February 2000 Asta MedicaTask Divest TemmlerResult Sold to RCO Pharma / 3iPress report / newspaper article "Asta Medica verkauft Temmler-Gruppe" Press report on 27th July 99 Jumer/Cherqui-Group FranceTask Divest GroupResult Sold to AlpharmaPress report / newspaper article "Nach Frankreich - Alpharma steigt ein" Published on 27th May 1999 in the German Newspaper "AMZ" (No. 10) American Home ProductsTask Divest DurachemieResult Sold to Merck KGaAPress report / newspaper article "Merck baut Pharmageschäft aus - Ewerb der Durachemie und des OTC-Geschäftes der Kytta Siegfried Pharma" Press report on 1st October 1997 Gehe AGTask Divest Pharma-DivisionResult - Jenapharm sold to Schering AG - Azupharma sold to Novartis - Aliud sold to STADA AG - GNR (France) sold to BASF-Pharma - Allphamed sold to PharbilPress report / newspaper article "Verkauf der Pharmaproduktion bringt Gehe 1,2 Milliarden DM" Published on 16th October 1996 in "Frankfurter Allgemeine Zeitung"<br> </font></p> </body>